AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Boston Children's Hospital / Dana-Farber Cancer Institute at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Boston Children's Hospital / Dana-Farber Cancer Institute brings 2 presentations to AMP 2026 in Seattle. Its programme centres on molecular diagnostics for paediatric and young adult cancers, with a second strand on what members need from AMP in clinical practice. The cancer work follows tumour profiling through to the decisions it changes in the clinic.
| Organization | AMP 2026 Attendance |
|---|---|
BC Boston Children's Hospital / Dana-Farber Cancer Institute Boston, MA | |
Paediatric hospital and cancer institute in Boston that jointly run childhood cancer care and molecular diagnostics. | Talk Fri, Nov 13 10:15am–11:00am From Profiling to Clinical Impact: Advancing Molecular Diagnostics for Pediatric and AYA Cancers Molecular profiling for children and young adults with cancer: what has improved, what blocks access, and how results reach patients. Workshop Fri, Nov 13 3:00pm–3:30pm The Practice Pulse: Identifying Where Members Need AMP Most (An AMP Clinical Practice Committee Open Forum) Where clinical practice gaps sit today, with member input steering which problems the committee takes on next. |
Find decision makers at Boston Children's Hospital / Dana-Farber Cancer Institute
Tell us what you sell and we’ll find the people at Boston Children's Hospital / Dana-Farber Cancer Institute most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction